Addition of testosterone to endocrine care for transgender women: a dose-finding and feasibility trial
The use of testosterone supplementation in transgender women seems feasible and safe in the short term. Although dosing requires personalized titration, stable testosterone levels can be established. A blinded, placebo-controlled, randomized clinical trial is needed to study the clinical benefit.
Authors
- Baudewijntje P.C. Kreukels (ORCID: https://orcid.org/0000-0002-9713-4835)
- Maurice A.G.M. Kroon (ORCID: https://orcid.org/0000-0002-0279-9691)
- Stephanie Both (ORCID: https://orcid.org/0000-0001-7327-4940)
- Noor C. Gieles (ORCID: https://orcid.org/0000-0002-4922-9469)
- Martin den Heijer (ORCID: https://orcid.org/0000-0003-3620-5617)
- Annemieke C. Heijboer (ORCID: https://orcid.org/0000-0002-6712-9955)
Institutions
- University Medical Center (US)
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1093/ejendo/lvae103
- Citations
- 1
- Primary Topic
- LGBTQ Health, Identity, and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.64
Funders
- Kyowa Kirin Pharmaceutical Development